Sirio Pharma Co., Ltd. (SHE:300791)

China · Delayed Price · Currency is CNY

21.02

+0.42 (2.04%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Vitamins & Nutrition Products	4.21B	3.58B	2.51B	2.37B	2.07B
Vitamins & Nutrition Products Growth	17.56%	42.87%	5.84%	14.62%	30.85%
Total	4.21B	3.58B	2.51B	2.37B	2.07B
Total Growth	17.56%	42.87%	5.84%	14.62%	30.85%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.66B	1.85B	1.49B	1.46B	1.28B
China Growth	-10.28%	24.11%	2.28%	14.06%	32.99%
Americas	1.67B	1.04B	540.90M	398.08M	265.76M
Americas Growth	59.56%	93.04%	35.88%	49.79%	-
Europe	604.48M	529.11M	395.52M	435.36M	461.58M
Europe Growth	14.25%	33.78%	-9.15%	-5.68%	5.59%
Other Areas	279.95M	157.83M	79.48M	77.34M	61.06M
Other Areas Growth	77.38%	98.56%	2.78%	26.66%	216.42%
Total	4.21B	3.58B	2.51B	2.37B	2.07B
Total Growth	17.56%	42.87%	5.84%	14.62%	30.85%

Source: S&P Global Market Intelligence.